General Information of the Compound
| Compound ID |
CP0405563
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-{3-[(5-Bromo-pyridin-2-yl)-(3,4-dichloro-benzyl)-amino]-propyl}-3-(2-pyridin-2-yl-ethyl)-thiourea
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H24BrCl2N5S
|
||||||||||||||||||
| Molecular Weight |
553.357
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc(CN(CCCNC(=S)NCCc2ccccn2)c2ccc(Br)cn2)cc1Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H24BrCl2N5S/c24-18-6-8-22(30-15-18)31(16-17-5-7-20(25)21(26)14-17)13-3-11-28-23(32)29-12-9-19-4-1-2-10-27-19/h1-2,4-8,10,14-15H,3,9,11-13,16H2,(H2,28,29,32)
Show/Hide
|
||||||||||||||||||
| InChIKey |
LEPLUZQACJKCSY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01505, Somatostatin receptor type 2
Protein ID: PT01398, Somatostatin receptor type 4